APVO Aptevo Therapeutics Inc.
$1.28▼ -14.67%
Healthcare
Other
Volume 80.0K
Avg Volume (10D) 31.5K
Key Metrics & Fundamentals
Market Cap
$2.32M
P/E Ratio
0.0
Div Yield
0.00%
52W Range
1.25 - 28.44
% vs 50 MA
-34.08%
% vs 200 MA
-71.44%
RSI-14
19.4
MACD Histogram
-0.0100
Beta (1Y vs SPY)
1.03
Free Cash Flow
-$5.45M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$6.41M
COGS
–
Operating Exp
$6.44M
Operating Income
-$6.44M
EBIT
-$6.44M
Pretax Income
-$6.36M
Net Income
-$6.36M
EPS (Diluted)
-5.31
Price & Volume History
Loading chart…
Recent News
APVO: Mipletamig Combination Therapy Leads to 21% Stem Cell Transplantation Rate
Zacks Small Cap Research · Oct 27, 2026 6:33 AM ET
Aptevo Reports Mipletamig Combination Therapy Enabled 21% of Frontline AML Patients to Advance to Potentially Curative Stem Cell Transplant
ACCESS Newswire · Oct 26, 2026 8:05 AM ET
Aptevo to Showcase Multispecific Platform at SITC 2026 Annual Meeting
ACCESS Newswire · Oct 14, 2026 8:46 AM ET
Aptevo Advances Next-Generation Trispecific Candidate Toward Clinical Development
ACCESS Newswire · Sep 24, 2026 8:05 AM ET
Aptevo Reports 93% Clinical Benefit Rate for Mipletamig Triplet in TP53-Mutated AML
InvestorsHub · Sep 3, 2026 10:19 AM ET
Aptevo Reports 93% Clinical Benefit Rate with Mipletamig Triplet in Difficult-to-Treat TP53-Mutated Frontline AML
ACCESS Newswire · Sep 3, 2026 8:05 AM ET
APVO: Focusing on Three Key Areas of Development
Zacks Small Cap Research · Aug 24, 2026 5:02 AM ET
Aptevo Provides 2Q26 Business Update and Reports Second Quarter Financial Results
ACCESS Newswire · Aug 14, 2026 8:05 AM ET
Aptevo Therapeutics Announces Closing of Existing Warrants Exercise and PIPE for $4.5 Million Gross Proceeds
ACCESS Newswire · Aug 13, 2026 4:05 PM ET
Aptevo Therapeutics Announces Exercise of Existing Warrants and PIPE for $4.5 Million Gross Proceeds
ACCESS Newswire · Aug 12, 2026 9:30 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See APVO's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.